Table of Content

1    INTRODUCTION    37
1.1    OBJECTIVES OF THE STUDY    37
1.2    MARKET DEFINITION & SCOPE    37
1.2.1    INCLUSIONS & EXCLUSIONS OF THE STUDY    38
1.2.2    MARKET SEGMENTATION    39
FIGURE 1    PATIENT REGISTRY SOFTWARE MARKET    39
1.2.3    YEARS CONSIDERED FOR THE STUDY    40
1.3    CURRENCY    40
TABLE 1    EXCHANGE RATES USED FOR CONVERSION TO USD    40
1.4    LIMITATIONS    40
1.5    STAKEHOLDERS    41
1.6    SUMMARY OF CHANGES    41
2    RESEARCH METHODOLOGY    42
2.1    RESEARCH APPROACH    42
FIGURE 2    RESEARCH DESIGN    42
2.1.1    SECONDARY RESEARCH    43
2.1.1.1    Key data from secondary sources    43
2.1.2    PRIMARY DATA    44
FIGURE 3    PRIMARY SOURCES    44
2.1.2.1    Key data from primary sources    45
2.1.2.2    Insights from primary experts    46
FIGURE 4    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    46
2.2    MARKET SIZE ESTIMATION    47
FIGURE 5    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS    47
FIGURE 6    CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PATIENT REGISTRY SOFTWARE MARKET (2021-2026)    49
FIGURE 7    CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS    49
2.3    MARKET BREAKDOWN & DATA TRIANGULATION    51
FIGURE 8    MARKET DATA TRIANGULATION METHODOLOGY    51
2.4    MARKET SHARE ANALYSIS    52
2.5    ASSUMPTIONS FOR THE STUDY    52
2.6    LIMITATIONS    52
2.6.1    METHODOLOGY-RELATED LIMITATIONS    52
2.7    RISK ASSESSMENT    53
TABLE 2    RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET    53

3    EXECUTIVE SUMMARY    54
FIGURE 9    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2021 VS. 2026 (USD MILLION)    54
FIGURE 10    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2021 VS. 2026 (USD MILLION)    55
FIGURE 11    PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2021 VS. 2026 (USD MILLION)    56
FIGURE 12    PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2021 VS. 2026 (USD MILLION)    57
FIGURE 13    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2021 VS. 2026 (USD MILLION)    58
FIGURE 14    PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2021 VS. 2026 (USD MILLION)    59
FIGURE 15    PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)    60
FIGURE 16    GEOGRAPHICAL SNAPSHOT OF PATIENT REGISTRY SOFTWARE MARKET    61
4    PREMIUM INSIGHTS    62
4.1    PATIENT REGISTRY SOFTWARE MARKET OVERVIEW    62
FIGURE 17    RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS DRIVING MARKET    62
4.2    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY AND COUNTRY (2020)    63
FIGURE 18    DISEASE REGISTRIES SEGMENT AND JAPAN ACCOUNTED
FOR LARGEST SHARES    63
4.3    PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES    64
FIGURE 19    CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD    64
4.4    REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2021−2026)    65
FIGURE 20    NORTH AMERICA TO DOMINATE PATIENT REGISTRY
SOFTWARE MARKET IN 2026    65
4.5    PATIENT REGISTRY SOFTWARE MARKET: DEVELOPING VS. DEVELOPED MARKETS    66
FIGURE 21    DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    66
5    MARKET OVERVIEW    67
5.1    INTRODUCTION    67
5.2    MARKET DYNAMICS    67
FIGURE 22    PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    67
5.2.1    MARKET DRIVERS    68
5.2.1.1    Government initiatives to build patient registries    68
5.2.1.2    Rising pressure to improve quality of care and reduce
healthcare costs    68
5.2.1.3    Rising adoption of EHRs and other eHealth solutions    69
5.2.1.4    Growing patient volume due to global outbreak of COVID-19    69
5.2.1.5    Growing use of patient registry data for post-marketing surveillance    69
5.2.2    MARKET RESTRAINTS    70
5.2.2.1    Privacy- and data security-related concerns    70
5.2.2.2    Shortage of trained and skilled resources    70
5.2.3    MARKET OPPORTUNITIES    70
5.2.3.1    Rising number of accountable care organizations    70
5.2.3.2    Emergence of cloud-based patient registry solutions    71
5.2.3.3    High adoption rate of subscription model    71
5.2.4    MARKET CHALLENGES    71
5.2.4.1    Lack of interoperability and integration    71
5.2.4.2    Reluctance to adopt advanced solutions    72
5.2.4.3    Lack of awareness    72
5.3    REGULATORY ANALYSIS    72
TABLE 3    KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICE CONNECTIVITY SOLUTIONS    73
5.3.1    INTEROPERABILITY STANDARDS    75
TABLE 4    KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM    75
TABLE 5    QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM    77
5.4    PRICING ANALYSIS    78
5.5    TECHNOLOGY ANALYSIS    78
5.6    ECOSYSTEM ANALYSIS    79
FIGURE 23    ECOSYSTEM ANALYSIS: PATIENT REGISTRY SOFTWARE MARKET    79
5.7    PATENT ANALYSIS    79
5.7.1    PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE    79
FIGURE 24    PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021)    80
5.7.2    JURISDICTION AND TOP APPLICANT ANALYSIS    80
FIGURE 25    TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT REGISTRIES PATENTS (JANUARY 2011 TO JUNE 2021)    81
FIGURE 26    TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT REGISTRY SOFTWARE PATENTS (JANUARY 2011 TO JUNE 2021)    81
6    INDUSTRY INSIGHTS    82
6.1    INTRODUCTION    82
6.2    INDUSTRY TRENDS    82
6.2.1    SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS    82
6.2.2    GROWING DEVELOPMENTS IN AUTOMATED DATA ENTRIES    82
6.3    IMPACT OF COVID-19 ON PATIENT REGISTRY SOFTWARE MARKET    83
7    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY    84
7.1    INTRODUCTION    85
TABLE 6    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    85
TABLE 7    PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    86
7.2    DISEASE REGISTRIES    86
TABLE 8    DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    87
TABLE 9    DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    87
7.2.1    DIABETES REGISTRIES    88
7.2.1.1    Growing obese and geriatric populations to drive market growth    88
TABLE 10    DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    88
TABLE 11    DIABETES REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    89
7.2.2    CARDIOVASCULAR REGISTRIES    89
7.2.2.1    Rising prevalence of heart diseases and strokes worldwide to drive market growth    89
TABLE 12    CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    90
TABLE 13    CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    90
7.2.3    CANCER REGISTRIES    91
7.2.3.1    Increasing need to manage growing number of cancer patients to propel market growth    91
TABLE 14    CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    92
TABLE 15    CANCER REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    92
7.2.4    RARE DISEASE REGISTRIES    93
7.2.4.1    Increasing funding for research on rare diseases and their treatments to boost market growth    93
TABLE 16    RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    93
TABLE 17    RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    94
7.2.5    ASTHMA REGISTRIES    94
7.2.5.1    Increasing prevalence of asthma significantly driving market growth    94
TABLE 18    ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    95
TABLE 19    ASTHMA REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    95
7.2.6    CHRONIC KIDNEY DISEASE REGISTRIES    96
7.2.6.1    Rising prevalence of chronic kidney diseases to drive market growth    96
TABLE 20    CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    96
TABLE 21    CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    97
7.2.7    ORTHOPEDIC REGISTRIES    97
7.2.7.1    Growing number of patients suffering from orthopedic diseases to drive market growth    97
TABLE 22    ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    98
TABLE 23    ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    98
7.2.8    OTHER DISEASE REGISTRIES    99
TABLE 24    OTHER DISEASE REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    99
7.3    HEALTH SERVICE REGISTRIES    100
7.3.1    CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES    100
TABLE 25    HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    100
TABLE 26    HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    101
7.4    PRODUCT REGISTRIES    101
TABLE 27    PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    101
TABLE 28    PRODUCT REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    102
7.4.1    MEDICAL DEVICE REGISTRIES    102
7.4.1.1    Strong government support and initiatives to drive demand for medical device registries    102
TABLE 29    MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    103
TABLE 30    MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    104
7.4.2    DRUG REGISTRIES    104
7.4.2.1    Increasing post-marketing surveillance of drugs to
drive market growth    104
TABLE 31    DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS    105
TABLE 32    DRUG REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    105
8    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE    106
8.1    INTRODUCTION    107
TABLE 33    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2019–2026 (USD MILLION)    107
8.2    STANDALONE SOFTWARE    107
8.2.1    STANDALONE SOFTWARE TO DOMINATE MARKET IN FORECAST PERIOD    107
TABLE 34    STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS    108
TABLE 35    STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    108
8.3    INTEGRATED SOFTWARE    109
8.3.1    INTEGRATED SOFTWARE SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD    109
TABLE 36    INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS    109
TABLE 37    INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    110
9    PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL    111
9.1    INTRODUCTION    112
TABLE 38    PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    112
9.2    SUBSCRIPTION MODEL    112
9.2.1    LOW COST OF SUBSCRIPTION MODELS TO SUPPORT SEGMENT GROWTH    112
TABLE 39    SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    113
9.3    OWNERSHIP MODEL    113
9.3.1    RISING ADOPTION OF INTEGRATED SOFTWARE MODEL TO SUPPORT SEGMENT GROWTH    113
TABLE 40    OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    114
10    PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL    115
10.1    INTRODUCTION    116
TABLE 41    PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2019–2026 (USD MILLION)    116
10.2    ON-PREMISE MODEL    116
10.2.1    ON-PREMISE SOLUTIONS REDUCE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES    116
TABLE 42    ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS    117
TABLE 43    ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    118
10.3    CLOUD-BASED MODEL    118
10.3.1    CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME    118
TABLE 44    CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS    119
TABLE 45    CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    120
11    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE    121
11.1    INTRODUCTION    122
TABLE 46    PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2019–2026 (USD MILLION)    122
11.2    COMMERCIAL DATABASES    122
11.2.1    COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED    122
TABLE 47    PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED
BY KEY MARKET PLAYERS    123
TABLE 48    PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES,
BY COUNTRY, 2019–2026 (USD MILLION)    123
11.3    PUBLIC DATABASES    124
11.3.1    PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES    124
TABLE 49    PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED
BY KEY MARKET PLAYERS    124
TABLE 50    PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES,
BY COUNTRY, 2019–2026 (USD MILLION)    125

12    PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY    126
12.1    INTRODUCTION    127
TABLE 51    PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    127
12.2    POPULATION HEALTH MANAGEMENT    127
12.2.1    INCREASING DEMAND FOR QUALITY CARE DRIVES ADOPTION
OF PHM SOLUTIONS    127
TABLE 52    PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)    128
12.3    PATIENT CARE MANAGEMENT    129
12.3.1    GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH    129
TABLE 53    PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)    130
12.4    MEDICAL RESEARCH & CLINICAL STUDIES    130
12.4.1    CONTINUOUS RESEARCH FOR COVID-19 VACCINE SUPPORTING
SEGMENT GROWTH    130
TABLE 54    PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2019–2026 (USD MILLION)    131
12.5    HEALTH INFORMATION EXCHANGE    131
12.5.1    INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS    131
TABLE 55    PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2019–2026 (USD MILLION)    132
12.6    POINT OF CARE    133
12.6.1    URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS
TO DRIVE GROWTH    133
TABLE 56    PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY, 2019–2026 (USD MILLION)    134
12.7    PRODUCT OUTCOME EVALUATION    134
12.7.1    INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES TO PROPEL MARKET GROWTH    134
TABLE 57    PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2019–2026 (USD MILLION)    135
13    PATIENT REGISTRY SOFTWARE MARKET, BY END-USER    136
13.1    INTRODUCTION    137
TABLE 58    PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    137
13.2    GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS    137
13.2.1    GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN END-USER MARKET    137
TABLE 59    PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2019–2026 (USD MILLION)    138
13.3    HOSPITALS & MEDICAL PRACTICES    139
13.3.1    DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES    139
TABLE 60    PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY COUNTRY, 2019–2026 (USD MILLION)    140
13.4    PRIVATE PAYERS    140
13.4.1    NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH    140
TABLE 61    PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)    141
13.5    PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES    141
13.5.1    EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL SEGMENT GROWTH    141
TABLE 62    PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION)    142
13.6    RESEARCH CENTERS    142
13.6.1    INCREASED CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS GROWTH    142
TABLE 63    PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS,
 BY COUNTRY, 2019–2026 (USD MILLION)    143
14    PATIENT REGISTRY SOFTWARE MARKET, BY REGION    144
14.1    INTRODUCTION    145
FIGURE 27    PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES    145
TABLE 64    PATIENT REGISTRY SOFTWARE MARKET, BY REGION,
2019–2026 (USD MILLION)    146
14.2    NORTH AMERICA    146
FIGURE 28    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT    147
TABLE 65    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    148
TABLE 66    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    148
TABLE 67    NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    148
TABLE 68    NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE,
–2026 (USD MILLION)    149
TABLE 69    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    149
TABLE 70    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    150
TABLE 71    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    150
TABLE 72    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    150
TABLE 73    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY FUNCTIONALITY, 2019–2026 (USD MILLION)    151
TABLE 74    NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)    151
14.2.1    US    151
14.2.1.1    Largest market for patient registry software    151
TABLE 75    US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    152
TABLE 76    US: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    153
TABLE 77    US: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    153
TABLE 78    US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2019–2026 (USD MILLION)    154
TABLE 79    US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    154
TABLE 80    US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2019–2026 (USD MILLION)    154
TABLE 81    US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2019–2026 (USD MILLION)    155
TABLE 82    US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    155
TABLE 83    US: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    156
14.2.2    CANADA    156
14.2.2.1    Launch of new government initiatives is expected to drive the adoption of patient registry software across the country    156
TABLE 84    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    157
TABLE 85    CANADA: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    157
TABLE 86    CANADA: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    157
TABLE 87    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    158
TABLE 88    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    158
TABLE 89    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    158
TABLE 90    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    159
TABLE 91    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    159
TABLE 92    CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    160
14.3    EUROPE    160
TABLE 93    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    161
TABLE 94    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    161
TABLE 95    EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    162
TABLE 96    EUROPE: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    162
TABLE 97    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    163
TABLE 98    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    163
TABLE 99    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    163
TABLE 100    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    164
TABLE 101    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    164
TABLE 102    EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    165
14.3.1    GERMANY    165
14.3.1.1    High healthcare spending to support adoption of patient registry software solutions    165
TABLE 103    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    166
TABLE 104    GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    166
TABLE 105    GERMANY: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    167
TABLE 106    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    167
TABLE 107    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    168
TABLE 108    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    168
TABLE 109    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    168
TABLE 110    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)    169
TABLE 111    GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    169
14.3.2    UK    170
14.3.2.1    Government initiatives to support market growth    170
TABLE 112    UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    170
TABLE 113    UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    171
TABLE 114    UK: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    171
TABLE 115    UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2019–2026 (USD MILLION)    172
TABLE 116    UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
 2019–2026 (USD MILLION)    172
TABLE 117    UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2019–2026 (USD MILLION)    172
TABLE 118    UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2019–2026 (USD MILLION)    173
TABLE 119    UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    173
TABLE 120    UK: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    174
14.3.3    FRANCE    174
14.3.3.1    Large number of COVID-19 cases to support market growth    174
TABLE 121    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    175
TABLE 122    FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
TABLE 123    FRANCE: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
TABLE 124    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    176
TABLE 125    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    176
TABLE 126    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    176
TABLE 127    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    177
TABLE 128    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    177
TABLE 129    FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    178
14.3.4    ITALY    178
14.3.4.1    Rising prevalence of chronic diseases to increase demand for patient registry software    178
TABLE 130    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    179
TABLE 131    ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    179
TABLE 132    ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    180
TABLE 133    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    180
TABLE 134    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    181
TABLE 135    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    181
TABLE 136    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2019–2026 (USD MILLION)    181
TABLE 137    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
 2019–2026 (USD MILLION)    182
TABLE 138    ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    182
14.3.5    SPAIN    183
14.3.5.1    Government initiatives to improve adoption of patient registry software and eHealth solutions to drive demand    183
TABLE 139    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    183
TABLE 140    SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    184
TABLE 141    SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    184
TABLE 142    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    185
TABLE 143    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    185
TABLE 144    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    185
TABLE 145    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    186
TABLE 146    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    186
TABLE 147    SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    187
14.3.6    REST OF EUROPE    187
TABLE 148    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    188
TABLE 149    ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    188
TABLE 150    ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    188
TABLE 151    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2019–2026 (USD MILLION)    189
TABLE 152    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    189
TABLE 153    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    189
TABLE 154    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2019–2026 (USD MILLION)    190
TABLE 155    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    190
TABLE 156    ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER,
2019–2026 (USD MILLION)    191
14.4    ASIA PACIFIC    191
FIGURE 29    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT    192
TABLE 157    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    193
TABLE 158    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    193
TABLE 159    ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    193
TABLE 160    ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    194
TABLE 161    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    194
TABLE 162    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    195
TABLE 163    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    195
TABLE 164    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    195
TABLE 165    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)    196
TABLE 166    ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    196
14.4.1    JAPAN    197
14.4.1.1    Highest adoption rates of EMR and patient registry software solutions    197
TABLE 167    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    197
TABLE 168    JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    198
TABLE 169    JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    198
TABLE 170    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    198
TABLE 171    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    199
TABLE 172    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    199
TABLE 173    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    199
TABLE 174    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    200
TABLE 175    JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    200
14.4.2    CHINA    201
14.4.2.1    Absence of a patient-centered model may challenge adoption of patient registry software    201
TABLE 176    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    201
TABLE 177    CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    202
TABLE 178    CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    202
TABLE 179    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    203
TABLE 180    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    203
TABLE 181    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    203
TABLE 182    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    204
TABLE 183    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    204
TABLE 184    CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    205
14.4.3    INDIA    205
14.4.3.1    One of the lucrative markets in eHealth field    205
TABLE 185    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2019–2026 (USD MILLION)    206
TABLE 186    INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    206
TABLE 187    INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    206
TABLE 188    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    207
TABLE 189    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2019–2026 (USD MILLION)    207
TABLE 190    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    207
TABLE 191    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    208
TABLE 192    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    208
TABLE 193    INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    209
14.4.4    REST OF ASIA PACIFIC    209
TABLE 194    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    210
TABLE 195    ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    210
TABLE 196    ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    210
TABLE 197    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    211
TABLE 198    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    211
TABLE 199    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    211
TABLE 200    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    212
TABLE 201    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION)    212
TABLE 202    ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2019–2026 (USD MILLION)    213
14.5    LATIN AMERICA    213
14.5.1    LOW ADOPTION RATE OF EHR SOLUTIONS    213
TABLE 203    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    214
TABLE 204    LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    214
TABLE 205    LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE,
 2019–2026 (USD MILLION)    214
TABLE 206    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    215
TABLE 207    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    215
TABLE 208    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    215
TABLE 209    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    216
TABLE 210    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)    216
TABLE 211    LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)    217

14.6    MIDDLE EAST & AFRICA    217
14.6.1    GROWING GOVERNMENT INVESTMENTS DRIVING ADOPTION OF PATIENT REGISTRIES    217
TABLE 212    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)    218
TABLE 213    MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    218
TABLE 214    MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    219
TABLE 215    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)    219
TABLE 216    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)    220
TABLE 217    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)    220
TABLE 218    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2019–2026 (USD MILLION)    220
TABLE 219    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY FUNCTIONALITY, 2019–2026 (USD MILLION)    221
TABLE 220    MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY END USER, 2019–2026 (USD MILLION)    221
15    COMPETITIVE LANDSCAPE    222
15.1    OVERVIEW    222
FIGURE 30    KEY PLAYER STRATEGIES    222
15.2    REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS    223
FIGURE 31    REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT REGISTRY
SOFTWARE MARKET    223
15.3    MARKET SHARE ANALYSIS    224
FIGURE 32    PATIENT REGISTRY SOFTWARE MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2020    224
15.4    COMPETITIVE LEADERSHIP MAPPING    225
15.4.1    STARS    225
15.4.2    EMERGING LEADERS    226
15.4.3    PERVASIVE PLAYERS    226
15.4.4    PARTICIPANTS    226
FIGURE 33    PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)    227
15.5    COMPETITIVE LEADERSHIP MAPPING FOR START-UPS    228
15.5.1    PROGRESSIVE COMPANIES    228
15.5.2    DYNAMIC COMPANIES    228
15.5.3    STARTING BLOCKS    228
15.5.4    RESPONSIVE COMPANIES    228
FIGURE 34    PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)    229

15.6    COMPETITIVE SCENARIO    230
15.6.1    PRODUCT LAUNCHES AND APPROVALS    230
TABLE 221    PRODUCT LAUNCHES & APPROVALS    230
15.6.2    DEALS    230
TABLE 222    DEALS (2018–2021)    230
15.7    COMPETITIVE BENCHMARKING    232
FIGURE 35    FOOTPRINTS OF COMPANY IN PATIENT REGISTRY SOFTWARE MARKET    232
TABLE 223    COMPANY BY TYPE OF REGISTRY FOOTPRINT (25 COMPANIES)    233
TABLE 224    COMPANY BY REGIONAL FOOTPRINT (25 COMPANIES)    234"
"16    COMPANY PROFILES    235
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1    IBM CORPORATION    235
FIGURE 36    IBM: COMPANY SNAPSHOT (2020)    236
16.2    IQVIA HOLDINGS    239
FIGURE 37    IQVIA HOLDINGS: COMPANY SNAPSHOT (2020)    239
16.3    OPENTEXT CORPORATION    242
FIGURE 38    OPENTEXT CORPORATION: COMPANY SNAPSHOT (2020)    242
16.4    OPTUM    245
FIGURE 39    OPTUM: COMPANY SNAPSHOT (2020)    245
16.5    PREMIER INC.    248
FIGURE 40    PREMIER: COMPANY SNAPSHOT    248
16.6    SYNEOS HEALTH    252
FIGURE 41    SYNEOS HEALTH: COMPANY SNAPSHOT (2020)    252
16.7    FIGMD    254
16.8    IMAGETREND, INC.    255
16.9    DACIMA SOFTWARE, INC.    257
16.10    GLOBAL VISION TECHNOLOGIES, INC.    258
16.11    IFA SYSTEMS AG    259
FIGURE 42    IFA SYSTEMS AG: COMPANY SNAPSHOT (2020)    259
16.12    MEDSTREAMING- M2S    261
16.13    MCKESSON CORPORATION    262
FIGURE 43    MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)    262
16.14    EVADO CLINICAL    264
16.15    WIRB COPERNICUS GROUP    265
16.16    ARBORMETRIX, INC.    267
16.17    CONDUENT, INC.    269
FIGURE 44    CONDUENT INC: COMPANY SNAPSHOT (2020)    269
16.18    ELEKTA AB    271
FIGURE 45    ELEKTA AB: COMPANY SNAPSHOT (2020)    271
16.19    ORDINAL DATA, INC.    273
16.20    ESO SOLUTIONS    274
16.21    LUMEDX    275
16.22    ARMUS CORP    275
16.23    CEDARON    276
16.24    PHAMAX AG    276
16.25    VERSAFORM SYSTEMS CORP    277
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17    APPENDIX    278
17.1    INSIGHTS OF INDUSTRY EXPERTS    278
17.2    DISCUSSION GUIDE    279
17.3    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    283
17.4    AVAILABLE CUSTOMIZATIONS    285
17.5    RELATED REPORTS    285
17.6    AUTHOR DETAILS    286